Conference abstractPublished 26 Jun 2017
A PET study with [11-C] Raclopride in Hemiparkinsonism model: Preliminary results on the effect of a TiO2DA matrix implanted in the caudate nucleus
National Autonomous University of Mexico, Mexico CICATA Legaria Unit, Instituto Politecnico Nacional, Mexico National Institute of Neurology and Neurosurgery, Mexico
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is now widely accepted that compensatory mechanisms are involved during the early phase of Parkinson's disease (PD) to delay the expression of motor symptoms. Our objective was to determine the effects on motor behavior in a TiO2DA implant inserted in the caudate in a hemiparkinsonism rat model and its correlation with the in vivo binding of [11-C] raclopride to D2 dopamine receptors in its basal ganglia. Each rat underwent a PET study, before and after treatment with microimplant. Male Wistar rats (250- 300 gr) were used and divided into 4 groups: Sham, Lesioned (Lx), Lx+implant and Implant. Post-lesion for 21 days anxiety behavior and locomotor activity of the rats of each group through the open field test was evaluated. The test was made in an acrylic box (with transparent walls and floor), whose floor is divided with painted black lines formingâÂ?Â?s squares and illuminated with floodlights. The test was recorded for five minutes; the following measurement parameters were assessed: total distance traveled and the number of crossed lines marked on the floor. The tests were recorded. In each group analysis of microPET was done, each rat underwent a PET study, before and after treatment with microimplant. The implant induced an increase in the in vivo binding of [11C] raclopride in the striatum of hemiparkinsonian rats. This observation indicates that there is a higher amount of transporters bound to striatal dopamine; higher dopamine levels were found in the Lx+Imp group than in the Lx group as well as a larger number of dopaminergic neurons in striatum in the histological analysis. This observation indicates that the microimplant with dopamine produce an increase in extracellular levels of dopamine sufficiently to inhibit raclopride binding, this effect probably due to dopamine release from TiO2DA matrix implanted in caudate nucleus.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S Hernandez Castro”
- BylineArticles whose byline prints “P Vergara-Aragon”
- BylineArticles whose byline prints “G Valverde-Aguilar”
- BylineArticles whose byline prints “David Diaz-Diaz”
- BylineArticles whose byline prints “Aurora Sanchez-Garcia”
- BylineArticles whose byline prints “Ketzalzin Meza-Aupart”
- BylineArticles whose byline prints “Aratxa Cabrera- Laguna”
- BylineArticles whose byline prints “Paul Jimenez-Prado”
